Q1 2024 Earnings

Revenue

$8M+40.6% YoY

Gross Profit

$5M59.2% margin

Operating Income

-$4M-55.4% margin

Net Income

-$4M-54.3% margin

EPS (Diluted)

$-0.16

QoQ Revenue Growth

+12.2%

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$2M

Total Assets

$54M

Total Liabilities

$19M

Stockholders' Equity

$35M

Cash & Equivalents

$35M

Metric	Current	Year Ago	Change
Revenue	$8M	$5M	+40.6%
Gross Profit	$5M	$3M	+41.3%
Operating Income	-$4M	-$6M	+25.9%
Net Income	-$4M	-$6M	+26.1%

Biologics And Drug Delivery

$4M37%

Functional Neurosurgery Navigation and Therapy - Disposable Products

$2M17%

Functional Neurosurgery Navigation and Therapy

$2M17%

Capital Equipment And Software

$1M12%

Capital Equipment And Software - Systems and Software Products

$1M10%

Biologics And Drug Delivery - Disposable Products

$553,0005%

Capital Equipment And Software - Services

$250,0002%